ipratropium bromide/salbutamol neutec 0.5/2.5 mg per 2.5 ml nebuliser solution
neutec inhaler ireland limited - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - salbutamol and ipratropium bromide
salbutamol-rl cfc-free salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose aerosol can
glaxosmithkline australia pty ltd - salbutamol sulfate -
teva-salbutamol hfa metered-dose aerosol
teva canada limited - salbutamol (salbutamol sulfate) - metered-dose aerosol - 100mcg - salbutamol (salbutamol sulfate) 100mcg - selective beta 2-adrenergic agonists
sandoz salbutamol solution
sandoz canada incorporated - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists
salbutamol k-haler
viatris limited - salbutamol sulfate 120ug equivalent to salbutamol 100 µg; - aerosol inhaler, metered dose - 100 mcg - active: salbutamol sulfate 120ug equivalent to salbutamol 100 µg excipient: ethanol norflurane oleic acid
salair
rex medical ltd - salbutamol sulfate 0.12mg equivalent to 100 mcg salbutamol - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 0.12mg equivalent to 100 mcg salbutamol excipient: ethanol norflurane oleic acid - salbutamol sulphate is indicated for the prevention and treatment of bronchospasm and acts on the ?2 (beta-2) adrenoceptors of bronchial muscle at therapeutic doses, with little or no action on the ?1 (beta-1) adrenoceptors of the heart. with its fast onset of action, it is particularly suitable for the management and prevention of attack in mild asthma and for the treatment of acute exacerbations in moderate to severe asthma. patients with unstable or severe asthma should not rely on bronchodilators as the main or only form of treatment. severe asthma requires regular medical assessment as death may occur. patients with severe asthma have constant symptoms and frequent exacerbations, with limited physical capacity, and pef values below 60% (predicted at baseline) with greater than 30% variability, usually not returning entirely to normal after a bronchodiliator. together with corticosteroid treatment, salair inhaler provides essential rescue medication for severe asthmatics in treating acute exace
salbutamol
origen pharmaceuticals limited - salbutamol sulfate 0.4 mg/ml - elixir - 2mg/5ml - active: salbutamol sulfate 0.4 mg/ml
salbutamol
origen pharmaceuticals limited - salbutamol sulfate 1 mg/ml - solution for infusion - 5mg/5ml - active: salbutamol sulfate 1 mg/ml
salbutamol
origen pharmaceuticals limited - salbutamol sulfate 0.5 mg/ml - solution for injection - 0.5 mg/ml - active: salbutamol sulfate 0.5 mg/ml
salbutamol respirator solution
origen pharmaceuticals limited - salbutamol sulfate 0.4 mg/ml - solution for inhalation - 2mg/5ml - active: salbutamol sulfate 0.4 mg/ml